Prostate Cancer
Clinical research at Regionshospital Nordjylland is centered on prostate cancer, with attention to advanced and metastatic disease. The sponsored trial activity reflects interest in symptom management and supportive care for patients with castration-resistant prostate cancer.
- Advanced prostate cancer
- Metastatic castration-resistant prostate cancer
- Oncology supportive care
Research activity in this area includes evaluation of treatment approaches aimed at improving patient comfort and addressing the clinical burden associated with late-stage urologic malignancy.
Cannabinoid-Based Symptom Management
The sponsor also shows interest in cannabinoid-based therapy within cancer care, particularly the use of cannabidiol in patients with severe disease. This area focuses on supportive treatment strategies relevant to pain management and reduction of opioid requirements.
- Cannabidiol
- Opioid-sparing treatment
- Cancer-related symptoms
These research interests place emphasis on improving tolerability and addressing symptom burden in individuals with advanced oncologic illness.
